Paul Zaydon
Dermatology · Pawtucket, RINPI 1700892726
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.9% of the total across 202 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by Novartis at 24.4% of the total. Reporting peaked in 2022 at $1,127 and has fallen 96.1% since, to $43 in 2025.
Across 202 payments — averaging $20.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$1K
- AbbVie$731
- Johnson & Johnson$625
- Amgen$361
- UCB, Inc.$299
- Lilly USA, LLC$260
- plus $918 from 14 others
What the payments were for
- Travel & lodging$50%
- Food & beverage$4,218100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 54 | $1,029 |
| AbbVie | 37 | $731 |
| Johnson & Johnson | 26 | $625 |
| Amgen | 14 | $361 |
| UCB, Inc. | 14 | $299 |
| Lilly USA, LLC | 11 | $260 |
| LEO Pharma Inc. | 10 | $222 |
| Pfizer | 7 | $131 |
| Dermavant Sciences, Inc. | 4 | $75 |
| Sanofi | 4 | $71 |
| Arcutis Biotherapeutics, Inc. | 3 | $70 |
| Sun Pharmaceutical Industries Inc. | 3 | $61 |
| Incyte Corporation | 3 | $58 |
| Boehringer Ingelheim | 2 | $50 |
| Genentech USA, Inc. | 3 | $47 |
| Regeneron Healthcare Solutions, Inc. | 2 | $30 |
| Galderma Laboratories, L.p. | 2 | $30 |
| E.r. Squibb & Sons, L.L.C. | 1 | $26 |
| Mayne Pharma Commercial LLC | 1 | $24 |
| Merz North America, Inc. | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Enbrel$125
How this compares
$4,223 in reported general payments places this provider in the 75th percentile of 61 dermatology providers in Rhode Island.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Hyclate | 18 | $393 |
| Acyclovir | 12 | $146 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Pawtucket
- David PomerantzPawtucket$25K
- Neil TobackPawtucket$3K
- John KellyEast Greenwich$97K
- Helena KuhnProvidence$63K
- Martin WeinstockProvidence$62K
- Farah MoustafaProvidence$51K
- Carlos WambierSouth Kingstown$41K
- Abrar QureshiProvidence$38K
- Gary WatermanMiddletown$16K
- Hua ZhouCranston$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.